NCT05442307 (BRIEF-A) is a NA clinical trial of asthma education in Prescription Pattern, sponsored by University Hospital Bispebjerg and Frederiksberg.

Who is sponsoring NCT05442307?

NCT05442307 is sponsored by University Hospital Bispebjerg and Frederiksberg.

What drugs are being tested in NCT05442307?

Interventions in NCT05442307: asthma education, Other education.

What condition does NCT05442307 study?

NCT05442307 studies Prescription Pattern.

Is NCT05442307 still recruiting?

NCT05442307 is currently status unknown. Last updated 5 July 2022.

Last reviewed 2022-07-05 · How we verify

NCT05442307: BRIEF-A

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Academic Detailing About Asthma

Status unknown NA Last updated 5 July 2022

What this trial tests

NA trial testing asthma education in Prescription Pattern in 360 participants. Status unknown.

Timeline

6 October 2021

Primary endpoint
1 November 2023

1 November 2023

Quick facts

Lead sponsor	University Hospital Bispebjerg and Frederiksberg
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	360
Start date	6 October 2021
Primary completion	1 November 2023
Estimated completion	1 November 2023
Sites	1 location across Denmark

Drugs / interventions tested

asthma education
Other education

Conditions studied

Prescription Pattern — all drugs for Prescription Pattern →

Sponsor

University Hospital Bispebjerg and Frederiksberg

Who can join

Eligibility, any sex, with Prescription Pattern. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

General practices in the Capital Region of Denmark are offered a short educational visit and are randomized to either asthma (intervention) or another topic (control). The change in prescription pattern from before to after the visit is compared between the intervention and control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital Bispebjerg and Frederiksberg trials

Trials by the same sponsor.

NCT07060586 — The Effect of Sphenopalatine Ganglion Block on Headache and Vasalgia · NA · completed
NCT06911411 — PALLIATIVE ASSESSMENT COHORT IN THE GERIATRIC EMERGENCY SETTING · not yet recruiting
NCT06405750 — Left Atrial Appendage Arrhythmogenic and Thrombogenic Substrate · NA · recruiting
NCT06532825 — Cardiac Autonomic Dysfunction As a Sign of Irreversible Advanced Heart Failure · recruiting
NCT06184581 — Lithium Versus Lamotrigine in Bipolar Disorder, Type II · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05442307 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Bispebjerg and Frederiksberg
Last refreshed: 5 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05442307.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing